Newsletter | October 22, 2019

10.22.19 -- How Virtual Are You Willing To Go?

How Virtual Are You Willing To Go?
Virtual trials promise to disrupt the clinical research environment, allowing patients to participate in trials from their homes using wearables, telemedicine, and treatments shipped right to their door. Here are three ways to adapt the virtual trial model to your unique research needs.
Navigating The Global Virtual Trials Regulatory Landscape

Sponsors must be cognizant of the regulatory landscape — which countries or regulatory agencies support virtual trials and which are still forming opinions — before launching a complex virtual research strategy involving participants in numerous countries. Learn how sponsors can steer through an evolving landscape, track local attitudes, and plan trials accordingly.

Digital Therapeutics And Virtual Trials: An Ideal Match

Digital therapeutics are showing the potential to be the next frontier for value-driven precision medicine. While there have only been a handful of digital therapeutics to receive clearance from regulators, this signals a profound shift in the way pharma is leveraging digital technology to drive value for patients while gaining market share. Virtual trial models are designed with the same goal in mind.

Long-Term Follow-Up Studies Go Virtual

Long-term follow-up studies can be expensive and time-consuming for investigators, sponsors, and patients. Learn how virtual models can improve patient retention in long-term follow-up studies, cutting the time, cost, and burden for patients and investigators.

Virtual Trials
Virtual trials bring studies directly to patients at home. See how combining technology, data science, and clinical expertise speeds recruitment, heightens retention, and improves data quality — all of which helps you accelerate timelines and confidently achieve your study goals.